News und Analysen
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
Especially if you're living on a fixed income, being able to bring in even $1,500 in extra money each year via dividends can be a big change for the better. But it's often difficult to figure out
Albemarle Earnings Surge 112%, and 2023 Outlook Raised on Higher Lithium Prices
Albemarle (NYSE: ALB) stock fell 1.8% on Thursday following the giant lithium producer's release on the prior afternoon of its second-quarter 2023 report.
The stock's modest decline might lead some
Albemarle (ALB) Q2 2023 Earnings Call Transcript
Is This Cathie Wood Chip Stock a Buy Right Now?
Semiconductor test equipment and robotics maker Teradyne (NASDAQ: TER) is currently the fourth largest holding in Cathie Wood's ARK Autonomous Technology & Robotics ETF (NYSEMKT: ARKQ). Wood and
Mosaic (MOS) Q2 2023 Earnings Call Transcript
Rollins (ROL) Q2 2023 Earnings Call Transcript
Can a New CEO Revitalize the Gap Brand? That's Precisely What This Person Did for Mattel's Barbie.
Few consumer stocks with as much brand recognition as Gap (NYSE: GPS) have performed so badly on the stock market. Gap, which also owns Banana Republic and Old Navy, has been a staple of American
Is This AI and Robotics Chip Stock a Buy Now?
Famed disruptive growth investor Cathie Wood, founder and CEO of Ark Invest, has made a name for herself as one of the most bullish voices on Wall Street. Despite this reputation, Wood and company
Viatris Stock: Bull vs. Bear
Even if you don't recognize the name Viatris (NASDAQ: VTRS), you may have come in very close contact with this pharma company. It sells a wide variety of generic drugs -- such as generic Zyrtec
1 Reason I Wouldn't Buy This High-Yielding Dividend Stock
A high-yielding dividend stock can generate lots of dividend income for your portfolio. But that doesn't mean you should buy a stock only because of its yield. Dividends are never guaranteed and
Better Pharma Buy: Viatris vs. Pfizer
Pfizer (NYSE: PFE) and Viatris (NASDAQ: VTRS) have a common past. That's because Viatris came about a few years ago when Pfizer's Upjohn business merged with generic drug giant, Mylan. Since, their
Missed Investing in Lithium Giant Albemarle? 1 Small Company Might Hold Similar Upside Potential.
As electric vehicle (EV) adoption soars, demand for lithium has followed suit. The element is a key ingredient in the making of lithium-ion batteries, which have been riding around in our pockets
Better High-Yield Dividend Stock: Altria or Viatris?
If you are looking for a high-yield dividend stock to boost your income, you might be interested in Altria (NYSE: MO) or Viatris (NASDAQ: VTRS). Both companies offer attractive dividend yields of
Why Invesco QQQ ETF Jumped 38.7% in the First Half of 2023
The Invesco QQQ (NASDAQ: QQQ) exchange-traded fund (ETF) soared in the first of the year, gaining 38.7% year to date through June 30, according to S&P Global Market Intelligence. As of July 14, the
3 Reasons to Buy Viatris Stock, and 1 Reason to Sell
Buying shares of a generic drug manufacturer like Viatris (NASDAQ: VTRS) isn't the right move for everyone. While most investors would look for such companies to have a long history of bulletproof
10 Best Stocks to Buy Now, Stock Market News, and Investing Q&A
The Invesco QQQ Trust (NASDAQ: QQQ) is up over 43% year to date, and investors are wondering what to do next. While large-cap tech names associated with artificial intelligence (AI) have been on a
Why BorgWarner Stock Was Sputtering This Week
A messy spinoff helped push down the value of automotive supplier BorgWarner's (NYSE: BWA) stock over the past few trading days. This was compounded by an analyst price target cut. According to data
Why BorgWarner Stock Is Down Big on Some Quote Services Today
On Monday, auto parts supplier BorgWarner (NYSE: BWA) completed the spinoff of its fuel systems and aftermarket businesses into a new publicly traded company. The all-stock split is creating
Wall Street Thinks Viatris Stock Will Rise 25% -- Could It Grow Even More?
For a generic drugmaker like Viatris (NASDAQ: VTRS), big spurts of growth are unlikely. The market for low-cost generic medications is competitive, and success is largely defined by maintaining
A Top Stock to Buy No Matter Who Wins the EV Race
Investors have seen Tesla's (NASDAQ: TSLA) massive success and begun looking to Rivian (NASDAQ: RIVN), Lucid (NASDAQ: LCID), Canoo (NASDAQ: GOEV), and even more for similar gains. It hasn't worked
Western Union México and Fundación Dondé Partner Up to Provide Cross-Border Remittance Services in Mexico
Western Union and Fundación Dondé, a Private Assistance Institution (I.A.P., Institución de Asistencia Privada), today announced an agreement to offer Western Union remittance services at 332
This Female CEO/CFO Partnership Is Breaking Barriers and Delivering Market-Beating Returns
While there are plenty of examples of successful female CEOs and CFOs in the industrial world (UPS CEO Carol Tome and General Electric's CFO Carolina Dybeck Happe spring to mind), it's not often you
Old Navy Fuels July 4th Road Trips with Free Gas
Old Navy is giving away free gas to customers hitting the road to celebrate Independence Day, one of the busiest holidays for car travel in the U.S.1 The brand will fuel up vehicles at select
Cathie Wood Prefers These AI Stocks to Nvidia. Should You?
Cathie Wood, the CEO of Ark Invest, famously sold shares of Nvidia at the beginning of 2022. Since then, surging demand for the company's industry-leading artificial intelligence (AI) data center
The Most Successful Hedge Fund Manager in History Is Selling Tesla Stock and Buying This Nasdaq Index Fund
Ken Griffin's Citadel reported a record profit of $16 billion last year, bring its total earnings to $66 billion since its inception in 1990. That makes Griffin the most successful hedge fund